Sheaff Brock Investment Advisors LLC Increases Holdings in bioAffinity Technologies, Inc. (NASDAQ:BIAF)

Sheaff Brock Investment Advisors LLC boosted its position in bioAffinity Technologies, Inc. (NASDAQ:BIAF) by 131.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 46,304 shares of the company’s stock after buying an additional 26,304 shares during the period. Sheaff Brock Investment Advisors LLC owned approximately 0.30% of bioAffinity Technologies worth $42,000 as of its most recent filing with the Securities & Exchange Commission.

bioAffinity Technologies Trading Up 0.6 %

Shares of BIAF stock opened at $0.81 on Tuesday. bioAffinity Technologies, Inc. has a 1-year low of $0.57 and a 1-year high of $3.62. The company has a market cap of $12.55 million, a price-to-earnings ratio of -0.98 and a beta of 2.95. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.02 and a quick ratio of 1.01. The stock has a 50 day simple moving average of $0.85 and a 200-day simple moving average of $1.33.

bioAffinity Technologies Profile

bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.